Table 1 Preoperative characteristic in patients with and without COVID-19 who underwent open cardiac surgery from March 2020 through December 2021.
From: Testing for coronarvirus disease 2019 before cardiac surgery—safe outcome of infected patients
COVID-19 (n = 69a) | Non COVID-19 (n = 1801) | P value | |
|---|---|---|---|
Age (years) | 62 (10) | 62 (13) | 0.90 |
Female gender | 27 (39.1) | 446 (24.8) | 0.01 |
BMI (kg/m2) | 28.4 (5) | 27.0 (6) | 0.04 |
Creatinine (µmol/L) | 79.4 (25.0) | 86 (39.1) | 0.15 |
EuroSCORE II | 4.0 (6.5) | 4.6 (6.9) | 0.40 |
Previous smoking | 36 (52.1) | 717 (39.8) | 0.23 |
Hypertension | 47 (68.1) | 1044 (58.0) | 0.12 |
Hyperlipidaemia | 39 (56.5) | 901 (50.0) | 0.35 |
Diabetes mellitus | 20 (29.0) | 341 (18.9) | 0.05 |
COPD | 12 (17.4) | 159 (8.8) | 0.01 |
LVEF ≤ 50% | 45 (65.2) | 524 (29.0) | < 0.001 |